Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Shattuck Labs, Inc. Common Stock (STTK)

Pharmaceutical Preparations

https://www.shattucklabs.com

Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.

500 W. 5TH STREET
AUSTIN, TX

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/09/2020

Market Cap

158,931,909

Shares Outstanding

47,140,000

Weighted SO

42,485,485

Total Employees

N/A

Upcoming Earnings

08/08/2024

Beta

1.7480

Last Div

0.0000

Range

1.33-11.76

Chg

0.0400

Avg Vol

434427

Mkt Cap

158931909

Exch

NASDAQ

Country

US

Phone

512 900 4690

DCF Diff

1.7742

DCF

1.5158

Div Yield

0.0000

P/S

38.5383

EV Multiple

-1.1783

P/FV

1.5290

Div Yield %

0.0000

P/E

-1.9832

PEG

-0.0773

Payout

0.0000

Current Ratio

7.6151

Quick Ratio

7.6151

Cash Ratio

4.0392

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

261.6281

CCC

-261.6281

Gross Margin

0.0453

Op Margin

-21.9581

Pretax Margin

-20.6799

Net Margin

-20.6799

Eff Tax Rate

-0.0343

ROA

-0.6631

ROE

-0.6865

ROCE

-0.7972

NI/EBT

1.0000

EBT/EBIT

0.9418

EBIT/Rev

-21.9581

Debt Ratio

0.0297

D/E

0.0345

LT Debt/Cap

0.0262

Total Debt/Cap

0.0334

Int Coverage

-96.6435

CF/Debt

-16.5567

Equity Multi

1.1627

Rec Turnover

0.0000

Pay Turnover

1.3951

Inv Turnover

0.0000

FA Turnover

0.3467

Asset Turnover

0.0321

OCF/Share

-1.2449

FCF/Share

-1.2459

Cash/Share

2.0741

OCF/Sales

-15.3322

FCF/OCF

1.0008

CF Coverage

-16.5567

ST Coverage

-74.6517

CapEx Coverage

-1193.0189

Div&CapEx Cov

-1193.0189

P/BV

1.5290

P/B

1.5290

P/S

38.5383

P/E

-1.9832

P/FCF

-2.5114

P/OCF

-2.6749

P/CF

-2.6749

PEG

-0.0773

P/S

38.5383

EV Multiple

-1.1783

P/FV

1.5290

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation